Suppr超能文献

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.

作者信息

Sanchez-Piedra Carlos, Diaz-Torne Cesar, Manero Javier, Pego-Reigosa José M, Rúa-Figueroa Íñigo, Gonzalez-Gay Miguel A, Gomez-Reino Juan, Alvaro-Gracia Jose M

机构信息

Research Unit, Sociedad Española de Reumatologia, Madrid, Madrid, Spain.

Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

出版信息

Ann Rheum Dis. 2020 Jul;79(7):988-990. doi: 10.1136/annrheumdis-2020-217948. Epub 2020 Jun 5.

Abstract
摘要

相似文献

1
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Ann Rheum Dis. 2020 Jul;79(7):988-990. doi: 10.1136/annrheumdis-2020-217948. Epub 2020 Jun 5.
3
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
4
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
Rheumatol Int. 2020 Oct;40(10):1593-1598. doi: 10.1007/s00296-020-04676-4. Epub 2020 Aug 13.
6
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.
Ann Rheum Dis. 2020 Jul;79(7):986-988. doi: 10.1136/annrheumdis-2020-217903. Epub 2020 May 28.
8
Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
Ann Rheum Dis. 2020 Nov;79(11):1393-1399. doi: 10.1136/annrheumdis-2020-217984. Epub 2020 Aug 7.
9
Biologics, spondylitis and COVID-19.
Ann Rheum Dis. 2020 Dec;79(12):1663-1665. doi: 10.1136/annrheumdis-2020-217941. Epub 2020 Jun 10.
10
What is the true incidence of COVID-19 in patients with rheumatic diseases?
Ann Rheum Dis. 2021 Feb;80(2):e18. doi: 10.1136/annrheumdis-2020-217615. Epub 2020 Apr 22.

引用本文的文献

3
Locomotive syndrome in rheumatoid arthritis patients during the COVID-19 pandemic.
Nagoya J Med Sci. 2022 Nov;84(4):799-812. doi: 10.18999/nagjms.84.4.799.
5
The effect of COVID-19 pandemic in a large series of patients with Takayasu arteritis.
Turk J Med Sci. 2022 Jun;52(3):565-570. doi: 10.55730/1300-0144.5347. Epub 2022 Jun 16.
8
Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2090176. doi: 10.1080/21645515.2022.2090176. Epub 2022 Jul 25.
9
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study.
Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221090296. doi: 10.1177/1759720X221090296. eCollection 2022.
10
COVID GEAS: COVID-19 National Survey in Patients With Systemic Autoimmune Diseases.
Front Med (Lausanne). 2022 Jan 27;8:808608. doi: 10.3389/fmed.2021.808608. eCollection 2021.

本文引用的文献

1
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
N Engl J Med. 2020 Jul 2;383(1):85-88. doi: 10.1056/NEJMc2009567. Epub 2020 Apr 29.
2
Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.
Lancet Rheumatol. 2020 May;2(5):e250-e253. doi: 10.1016/S2665-9913(20)30095-3. Epub 2020 Apr 16.
3
COVID-19 and immunomodulation in IBD.
Gut. 2020 Jul;69(7):1335-1342. doi: 10.1136/gutjnl-2020-321269. Epub 2020 Apr 17.
4
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
5
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Autoimmun Rev. 2020 May;19(5):102523. doi: 10.1016/j.autrev.2020.102523. Epub 2020 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验